相关实验视频

Updated: Jan 29, 2026

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium

An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium

Published on: December 17, 2018

研究进展诱导肝脏巨细胞中的毒性

Jiongfei Chen¹, Zhaoan Wang², Wangying Li²

¹Department of the Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.

|January 28, 2026

概括

暴露会通过引起氧化应激和破坏细胞功能来损害肝脏巨细胞. 本综述探讨了的使用情况.

科学领域:

环境毒理学环境毒理学
肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

(Cd) 是一种有毒的环境污染物,通过多种机制影响人类健康.
肝脏巨细胞对肝脏健康至关重要,但它们在重金属诱导的肝脏损伤中的作用未得到充分研究.
了解肝脏巨细胞中的Cd毒性对于解决重金属相关肝脏疾病至关重要.

研究的目的:

审查肝细胞巨中诱导毒性的分子机制.
检查如何影响巨细胞功能和肝脏免疫代谢.
为Cd相关肝脏疾病的新型预防和治疗策略提供基础.

主要方法:

文献综述综合了目前关于在肝细胞巨中毒性的研究.
专注于分子机制,包括氧化应激,信号通路 (NF-κB, Nrf2),基因转录和亡.
对对巨分化 (M1/M2) 和肝脏免疫代谢的影响的分析.

主要成果:

会诱导氧化应激,并破坏肝脏巨细胞中的平衡.
转录因子NF-κB和Nrf2的激活导致信号级联的改变.
促进M1/M2巨细胞极化转移,细胞损伤,细胞亡,并加剧肝炎和纤维化.

结论:

肝脏巨细胞中的毒性涉及氧化应激,受损的平衡和改变的信号通路.
引起的巨功能障碍显著影响肝脏免疫代谢和疾病进展.
需要进一步的研究,以制定有针对性的策略,预防和治疗引起的肝损伤.

关键词:

库弗弗细胞是库弗弗细胞.和是最重要的元素.这是一种重金属,重金属.肝脏的巨细胞肝毒性肝毒性肝毒性免疫代谢的免疫代谢.

更多相关视频

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Hepatic Portal System

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

Overview of Advanced Functional Groups

Overview of Advanced Functional Groups

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.

Extraction: Advanced Methods

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...

Toxic Reactions: Overview

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...